Quest Diagnostics (DGX) Gains from Investment Securities (2009 - 2026)

Quest Diagnostics has disclosed Gains from Investment Securities across 18 years of filings, most recently posting $37.0 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $37.0 million, up 3600.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.0 million (up 3950.0% YoY), and the FY2025 annual result was $45.0 million, up 87.5% from the prior year.
• Gains from Investment Securities came in at $37.0 million for Q1 2026 at Quest Diagnostics, up from $25.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $55.0 million in Q3 2024 to a low of -$60.0 million in Q2 2022.
• The 5-year median for Gains from Investment Securities is $3.0 million (2023), against an average of $4.5 million.
• Across the five-year window, Gains from Investment Securities plunged 1900.0% in 2024 and soared 3600.0% in 2026, its largest moves.
• Quest Diagnostics' Gains from Investment Securities stood at -$29.0 million in 2022, then soared by 196.55% to $28.0 million in 2023, then soared by 96.43% to $55.0 million in 2024, then slumped by 54.55% to $25.0 million in 2025, then soared by 48.0% to $37.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $37.0 million (Q1 2026), $25.0 million (Q4 2025), and -$22.0 million (Q3 2025), per Business Quant data.